Ali Zarina S, Bailey Robert L, Daniels Lawrence B, Vakhshori Venus, Lewis Daniel J, Hossain Alisha T, Sitterley Karlyndsay Y, Lee John Y K, Storm Phillip B, Heuer Gregory G, Stein Sherman C
Department of Neurosurgery, University of Pennsylvania; and.
J Neurosurg Pediatr. 2014 Feb;13(2):178-88. doi: 10.3171/2013.11.PEDS1320. Epub 2013 Dec 6.
No clear treatment guidelines for pediatric craniopharyngiomas exist. The authors developed a decision analytical model to evaluate outcomes of 4 surgical approaches for craniopharyngiomas in children, including attempted gross-total resection (GTR), planned subtotal removal plus radiotherapy, biopsy plus radiotherapy, and endoscopic resections of all kinds.
Pooled data, including the authors' own experience, were used to create evidence tables, from which incidence, relative risks, and summary outcomes in quality-adjusted life years (QALYs) were calculated for the 4 management strategies.
Quality-adjusted life years at the 5-year follow-up were 2.3 ± 0.1 for attempted GTR, 2.9 ± 0.2 for planned subtotal removal plus radiotherapy, 3.9 ± 0.2 for biopsy plus radiotherapy, and 3.7 ± 0.2 for endoscopic resection (F = 17,150, p < 0.001). Similarly, QALYs at 10-year follow-up were 4.5 ± 0.2 for attempted GTR, 5.7 ± 0.5 for planned subtotal removal plus radiotherapy, and 7.8 ± 0.5 for biopsy plus radiotherapy (F = 6,173, p < 0.001). On post hoc pairwise comparisons, the differences between all pairs compared were also highly significant (p < 0.001). Since follow-up data at 10 years are lacking for endoscopic cases, this category was excluded from 10-year comparisons.
Biopsy with subsequent radiotherapy is the preferred approach with respect to improved overall quality of life. While endoscopic approaches also show promise in preserving quality of life at five-year follow-up, there are not sufficient data to draw conclusions about this comparison at 10 years.
目前尚无针对儿童颅咽管瘤的明确治疗指南。作者开发了一种决策分析模型,以评估儿童颅咽管瘤4种手术方法的疗效,包括尝试全切除(GTR)、计划性次全切除加放疗、活检加放疗以及各种类型的内镜切除术。
汇总的数据,包括作者自身的经验,用于创建证据表,据此计算4种治疗策略的发病率、相对风险以及质量调整生命年(QALY)的汇总结果。
5年随访时,尝试GTR的质量调整生命年为2.3±0.1,计划性次全切除加放疗为2.9±0.2,活检加放疗为3.9±0.2,内镜切除术为3.7±0.2(F = 17,150,p < 0.001)。同样,10年随访时,尝试GTR的QALY为4.5±0.2,计划性次全切除加放疗为5.7±0.5,活检加放疗为7.8±0.5(F = 6,173,p < 0.001)。在事后两两比较中,所有比较的组间差异也均具有高度显著性(p < 0.001)。由于缺乏内镜手术病例的10年随访数据,该类别被排除在10年比较之外。
后续放疗的活检是改善总体生活质量的首选方法。虽然内镜手术方法在5年随访时也显示出有望保留生活质量,但尚无足够数据得出10年时该比较的结论。